Pathophysiologic analysis of peripheral blood lymphocytes from patients with primary immunodeficiency. I. Ig synthesis by peripheral blood lymphocytes stimulated with either pokeweed mitogen or Epstein-Barr virus in vitro. NLM AIDSLINE Important note: Information in this article was accurate in 1981. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Pathophysiologic analysis of peripheral blood lymphocytes from patients with primary immunodeficiency. I. Ig synthesis by peripheral blood lymphocytes stimulated with either pokeweed mitogen or Epstein-Barr virus in vitro.

J Immunol. 1981 Jul;127(1):311-5. Unique Identifier : AIDSLINE MED/81216658
Mitsuya H; Osaki K; Tomino S; Katsuki T; Kishimoto S


Abstract: In the present study 5 patients with common variable hypogammaglobulinemia (CVH) and 4 patients with selective IgA deficiency (IgA-D) were analyzed for the cellular defects responsible for impaired Ig synthesis with use of peripheral blood lymphocytes stimulated with either PWM or EBV in vitro. By the use of co-culture with PWM, all the patients examined had intrinsic B cell defects restricted to the synthesis of Ig class corresponding to the low or absent Ig class(es) in the sera. Two types of excessive suppressor T activity were found, which were abrogated by irradiation. One was isotype-nonspecific and the other was IgA-specific. Moreover, failure of IgA-specific helper T activity was demonstrated. The use of EBV as an agent that polyclonally activates B cells independently of T cells and monocytes should allow a clearer delineation of the level of the B cell defects. When co-cultured with EBV, B cells from 3 patients with CVH produced normal to subnormal quantities of IgM although they could produce no IgM upon co-culturing with normal T cells and PWM. B cells from 2 patients with CVH could produce IgM normally by stimulation with either PWM or EBV; however, there was no restoration to produce IgG or IgA in these patients. In addition, B cells from 2 patients with IgA-D produced not only IgG and IgM but also IgA almost normally at 4 days after in vitro stimulation with EBV.
Keywords: Adolescence Adult Agammaglobulinemia/IMMUNOLOGY/*PHYSIOPATHOLOGY B-Lymphocytes/IMMUNOLOGY Child Dysgammaglobulinemia/IMMUNOLOGY/*PHYSIOPATHOLOGY DNA/BIOSYNTHESIS Herpesvirus 4, Human/IMMUNOLOGY Human IgA/*DEFICIENCY Immunoglobulins/*BIOSYNTHESIS Immunoglobulins, Surface/BIOSYNTHESIS Lymphocytes/IMMUNOLOGY Middle Age Pokeweed Mitogens/PHARMACOLOGY Support, Non-U.S. Gov't JOURNAL ARTICLE

KWDadolescenceadultagammaglobulinemia/immunology/KWDphysiopathologyb-lymphocytes/immunologychilddysgammaglobulinemia/immunology/KWDphysiopathologydna/biosynthesisherpesvirus4,human/immunologyhumaniga/KWDdeficiencyimmunoglobulins/KWDbiosynthesisimmunoglobulins,surface/biosynthesislymphocytes/immunologymiddleagepokeweedmitogens/pharmacologysupport,non-uKWDsKWDgov'tjournalarticle
811030
M81A0004


Copyright © 1981 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1981. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1981. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .